Physician profile
Connor Sholtis
NPI 1477132231
$4,030.20
in general payments reported to CMS, 2019-2025
9 companies · $1,015 in 2025
The $1,015 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,225 · 2023: $476 · 2024: $1,314 · 2025: $1,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,804.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $1,419.41 | 2021-2023 | |
| Stryker Corporation | $972.04 | 2024-2025 | Gamma, Na |
| Axogen | $559.58 | 2024 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Solventum Corporation | $269.36 | 2024-2025 | Prevena |
| Innovation Technologies INC | $255.08 | 2023-2025 | Irrisept |
| Depuy Synthes Sales INC. | $250.33 | 2025 | Fms Duo, Dynacord, Healix Knotless Peek |
| Si-Bone, INC. | $140.31 | 2025 | |
| Kci USA, INC. | $132.84 | 2023 | |
| Overture Orthopaedics | $31.25 | 2025 | Overtureti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connor Sholtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.